Onderneming Maravai LifeSciences Holdings, Inc.
Aandelen
MRVI
US56600D1072
Biotechnologie & Medisch Onderzoek
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
7,7 USD | +1,58% | +5,48% | +17,56% |
10/04 | MARAVAI LIFESCIENCES HOLDINGS, INC. : Craig-Hallum handhaaft koopadvies | ZM |
08/04 | MARAVAI LIFESCIENCES HOLDINGS, INC. : RBC Capital Markets herhaalt koopadvies | ZM |
Vakgebied
Aantal werknemers: 650
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Nucleic Acid Production
77,8
%
| 813 | 92,1 % | 225 | 77,8 % | -72,36% |
Biologics Safety Testing
22,2
%
| 70 | 7,9 % | 64 | 22,2 % | -8,23% |
Eliminations
0,0
%
| 0 | 0,0 % | 0 | 0,0 % | -57,14% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
North America
48,8
%
| 339 | 38,4 % | 141 | 48,8 % | -58,45% |
Asia Pacific
33,7
%
| 110 | 12,4 % | 97 | 33,7 % | -11,25% |
EMEA
17,3
%
| 433 | 49,0 % | 50 | 17,3 % | -88,47% |
Latin and Central America
0,2
%
| 1 | 0,1 % | 1 | 0,2 % | -34,78% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
William Martin
CEO | Chief Executive Officer | 49 | 30-09-22 |
Carl Hull
FOU | Founder | 66 | 01-03-14 |
Kevin Herde
DFI | Director of Finance/CFO | 53 | 01-05-17 |
Mike Houston
CTO | Chief Tech/Sci/R&D Officer | - | - |
Kate Broderick
CTO | Chief Tech/Sci/R&D Officer | - | 01-01-22 |
Peter Leddy
ADM | Chief Administrative Officer | 59 | 27-06-22 |
Deb Hart
IRC | Investor Relations Contact | - | - |
Christine Dolan
PRN | Corporate Officer/Principal | 56 | 10-10-17 |
Kurt Oreshack
LAW | General Counsel | 44 | 01-11-20 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Dean Mihas
BRD | Director/Board Member | 57 | 01-03-16 |
Sean Cunningham
BRD | Director/Board Member | 48 | 01-03-16 |
Gregory Lucier
BRD | Director/Board Member | 60 | 01-01-20 |
Susannah Gray
BRD | Director/Board Member | 63 | 01-11-20 |
Carl Hull
FOU | Founder | 66 | 01-03-14 |
John DeFord
BRD | Director/Board Member | 62 | 20-07-23 |
Director/Board Member | 46 | 01-03-16 | |
Murali Prahalad
BRD | Director/Board Member | 52 | 01-08-16 |
Jessica Hopfield
BRD | Director/Board Member | 59 | 19-11-20 |
Anat Ashkenazi
BRD | Director/Board Member | 51 | 19-11-20 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 119 094 026 | 0 | 0 | 42,76 % |
Aandeel B | 1 | 132 305 845 | 107 502 085 ( 81,25 %) | 0 |
Bedrijfsgegevens
Maravai Lifesciences Holdings, Inc.
10770 Wateridge Circle Suite 200
92121, San Diego
+
http://www.maravai.comSector
Verkoop per activiteit
Verkoop per regio
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+17,56% | 1,02 mld. | |
-20,45% | 10,82 mld. | |
+43,17% | 3,25 mld. | |
-35,86% | 2,11 mld. | |
-17,21% | 2,08 mld. | |
-29,81% | 1,48 mld. | |
-4,37% | 733 mln. | |
-37,00% | 391 mln. | |
-46,94% | 377 mln. | |
+13,32% | 332 mln. |
- Beurs
- Aandelen
- Koers MRVI
- Onderneming Maravai LifeSciences Holdings, Inc.